Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Obstructive Lung Diseases

  Free Subscription


Articles published in Eur Respir J

Retrieve available abstracts of 246 articles:
HTML format
Text format



Single Articles


    April 2018
  1. LOEWEN K, Monchka B, Mahmud SM, Jong G', et al
    Prenatal antibiotic exposure and childhood asthma: a population-based study.
    Eur Respir J. 2018 Apr 20. pii: 13993003.02070-2017.
    PubMed     Text format     Abstract available


  2. TSAI YH, Parker JS, Yang IV, Kelada SNP, et al
    Meta-Analysis of Airway Epithelia Gene Expression in Asthma.
    Eur Respir J. 2018 Apr 12. pii: 13993003.01962-2017.
    PubMed     Text format     Abstract available


  3. TAKAHASHI K, Pavlidis S, Ng Kee Kwong F, Hoda U, et al
    Sputum proteomics and airway cell transcripts of current and ex-smokers with severe asthma in U-BIOPRED: an exploratory analysis.
    Eur Respir J. 2018 Apr 12. pii: 13993003.02173-2017.
    PubMed     Text format     Abstract available


  4. HAVET A, Zerimech F, Sanchez M, Siroux V, et al
    Outdoor air pollution, exhaled 8-isoprostane and current asthma in adults: the EGEA study.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


    March 2018
  5. HANCOX RJ, Pavord ID, Sears MR
    Associations between blood eosinophils and decline in lung function among adults with and without asthma.
    Eur Respir J. 2018 Mar 21. pii: 13993003.02536-2017.
    PubMed     Text format     Abstract available


  6. HUMBERT M, Taille C, Mala L, Le Gros V, et al
    Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study.
    Eur Respir J. 2018 Mar 15. pii: 13993003.02523-2017.
    PubMed     Text format     Abstract available


  7. SHTEINBERG M, Stein N, Adir Y, Ken-Dror S, et al
    Prevalence, risk factors and prognosis of Non tuberculous mycobacteria infection among people with bronchiectasis: a population survey.
    Eur Respir J. 2018 Mar 15. pii: 13993003.02469-2017.
    PubMed     Text format    


  8. CHANOINE S, Sanchez M, Pin I, Temam S, et al
    Multimorbidity-medications and poor asthma prognosis.
    Eur Respir J. 2018 Mar 15. pii: 13993003.02114-2017.
    PubMed     Text format     Abstract available


  9. TO T, Feldman LY, Zhu J, Gershon AS, et al
    Asthma Health Services Utilization Before, During, and After Pregnancy: A Population-Based Cohort Study.
    Eur Respir J. 2018 Mar 8. pii: 13993003.00209-2018.
    PubMed     Text format     Abstract available


  10. LEE J, Ren Tay T, Radhakrishna N, Hore-Lacy F, et al
    Non-adherence in the era of severe asthma biologics and thermoplasty.
    Eur Respir J. 2018 Mar 8. pii: 13993003.01836-2017.
    PubMed     Text format     Abstract available


  11. DIJK FN, Xu C, Melen E, Carsin AE, et al
    Genetic regulation of IL1RL1 methylation and IL1RL1-a protein levels in asthma.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  12. HESTER KLM, Newton J, Rapley T, Ryan V, et al
    Information and education provision in bronchiectasis: co-development and evaluation of a novel patient-driven resource in a digital era.
    Eur Respir J. 2018 Mar 1. pii: 13993003.02402-2017.
    PubMed     Text format    


    February 2018
  13. PERRY MM, Lavender P, Scott Kuo CH, Galea F, et al
    DNA methylation modules in airway smooth muscle are associated with asthma severity.
    Eur Respir J. 2018 Feb 15. pii: 13993003.01068-2017.
    PubMed     Text format    


  14. TURNER S, Fielding S, Devereux G
    First trimester fetal size and prescribed asthma medication at 15 years of age.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  15. NAGAKUMAR P, Gambir N, Sanghani N, Hall P, et al
    Role of a prolonged inpatient admission when evaluating children with problematic severe asthma.
    Eur Respir J. 2018;51.
    PubMed     Text format    



  16. "Global strategy for asthma management and prevention: GINA executive summary." E.D. Bateman, S.S. Hurd, P.J. Barnes, J. Bousquet, J.M. Drazen, J.M. FitzGerald, P. Gibson, K. Ohta, P. O'Byrne, S.E. Pedersen, E. Pizzichini, S.D. Sullivan, S.E. Wenzel a
    Eur Respir J. 2018;51.
    PubMed     Text format    


  17. MARTINEZ-GARCIA MA
    Pseudomonas aeruginosa infection and exacerbations in bronchiectasis: more questions than answers.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  18. ARAUJO D, Shteinberg M, Aliberti S, Goeminne PC, et al
    The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  19. LAVIGNE E, Belair MA, Rodriguez Duque D, Do MT, et al
    Effect modification of perinatal exposure to air pollution and childhood asthma incidence.
    Eur Respir J. 2018 Feb 1. pii: 13993003.01884-2017.
    PubMed     Text format     Abstract available


  20. SHAW D
    Putting the brake on accelerated lung function decline in asthma.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  21. GRZESKOWIAK LE, Smithers LG, Grieger JA, Bianco-Miotto T, et al
    Asthma treatment impacts time to pregnancy: evidence from the international SCOPE study.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  22. COUMOU H, Westerhof GA, de Nijs SB, Zwinderman AH, et al
    Predictors of accelerated decline in lung function in adult-onset asthma.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  23. CELLI BR, Locantore N, Tal-Singer R, Riley J, et al
    Emphysema and extrapulmonary tissue loss in COPD: a multi-organ loss of tissue phenotype.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  24. PEKKANEN J, Valkonen M, Taubel M, Tischer C, et al
    Indoor bacteria and asthma in adults: a multicentre case-control study within ECRHS II.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  25. HACCURIA A, Van Muylem A, Malinovschi A, Doan V, et al
    Small airways dysfunction: the link between allergic rhinitis and allergic asthma.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


    January 2018
  26. MANISCALCO M, Paris D, Melck DJ, Molino A, et al
    Differential diagnosis between newly diagnosed asthma and chronic obstructive pulmonary disease using exhaled breath condensate metabolomics: a pilot study.
    Eur Respir J. 2018 Jan 18. pii: 13993003.01825-2017.
    PubMed     Text format    


  27. CHALMERS JD, Polverino E
    Macrolides, mucoactive drugs and adherence for the management of bronchiectasis.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  28. GUAN WJ, Huang Y, Chen CL, Chen RC, et al
    Macrolides, mucoactive drugs and adherence for the management of bronchiectasis.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  29. JORUP C, Lythgoe D, Bisgaard H
    Budesonide/formoterol maintenance and reliever therapy in adolescent patients with asthma.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  30. SULAIMAN I, Greene G, MacHale E, Seheult J, et al
    A randomised clinical trial of feedback on inhaler adherence and technique in patients with severe uncontrolled asthma.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  31. GAGA M, Samitas K, Zervas E
    Inhaler adherence in severe asthma: is there an electronic solution?
    Eur Respir J. 2018;51.
    PubMed     Text format    


  32. TONG X, Wang D, Liu S, Ma Y, et al
    Can YKL-40 be used as a biomarker and therapeutic target for adult asthma?
    Eur Respir J. 2018;51.
    PubMed     Text format    


  33. WONG C, Sullivan C, Jayaram L
    ELTGOL airway clearance in bronchiectasis: laying the bricks of evidence.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  34. CHALMERS JD, Ringshausen FC, Harris B, Elborn JS, et al
    Cross-infection risk in patients with bronchiectasis: a position statement from the European Bronchiectasis Network (EMBARC), EMBARC/ELF patient advisory group and European Reference Network (ERN-Lung) Bronchiectasis Network.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  35. MUNOZ G, de Gracia J, Buxo M, Alvarez A, et al
    Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trial.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  36. CHOTIRMALL SH, Chalmers JD
    RESPIRE: breathing new life into bronchiectasis.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  37. AKSAMIT T, De Soyza A, Bandel TJ, Criollo M, et al
    RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  38. DE SOYZA A, Aksamit T, Bandel TJ, Criollo M, et al
    RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


    December 2017
  39. KOURI A, Boulet LP, Kaplan A, Gupta S, et al
    Asthma control and action plans.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  40. BOUSQUET J, Brusselle G, Buhl R, Busse WW, et al
    Care pathways for the selection of a biologic in severe asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  41. AMIRAV I, Newhouse MT
    Asthma control and action plans.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  42. MORJARIA JB, Rigby AS, Morice AH
    Asthma phenotypes: do cough and wheeze predict exacerbations in persistent asthma?
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  43. ARAUJO D, Shteinberg M, Aliberti S, Goeminne PC, et al
    Standardised classification of the aetiology of bronchiectasis using an objective algorithm.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  44. SONG Y, Khoo SK, Lee KH, Makela M, et al
    Dual responses of CD14 methylation to distinct environments: a role in asthma and allergy.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  45. ANDRIANJAFIMASY M, Zerimech F, Akiki Z, Huyvaert H, et al
    Oxidative stress biomarkers and asthma characteristics in adults of the EGEA study.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  46. MCDONALD VM, Yorke J
    Adherence in severe asthma: time to get it right.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  47. DESLEE G, Leroy S, Perotin JM, Mal H, et al
    Two-year follow-up after endobronchial coil treatment in emphysema: results from the REVOLENS study.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  48. JOCHMANN A, Artusio L, Jamalzadeh A, Nagakumar P, et al
    Electronic monitoring of adherence to inhaled corticosteroids: an essential tool in identifying severe asthma in children.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


    November 2017
  49. LIPWORTH BJ, Jabbal S
    Un-diagnosing persistent adult asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  50. SALEH AD, Kwok B, Brown JS, Hurst JR, et al
    Correlates and assessment of excess cardiovascular risk in bronchiectasis.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  51. KOLEVA PT, Tun HM, Konya T, Guttman DS, et al
    Sex-specific impact of asthma during pregnancy on infant gut microbiota.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  52. BOURDIN A, Molinari N, Vachier I, Pahus L, et al
    Mortality: a neglected outcome in OCS-treated severe asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format    


    October 2017
  53. VAN DEN WIJNGAART LS, Roukema J, Boehmer ALM, Brouwer ML, et al
    A virtual asthma clinic for children: fewer routine outpatient visits, same asthma control.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  54. DUMAS O, Wiley AS, Quinot C, Varraso R, et al
    Occupational exposure to disinfectants and asthma control in US nurses.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  55. VAN DEN WIJNGAART LS, Kievit W, Roukema J, Boehmer ALM, et al
    Online asthma management for children is cost-effective.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  56. GOMEZ JL, Yan X, Holm CT, Grant N, et al
    Characterisation of asthma subgroups associated with circulating YKL-40 levels.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available



  57. "Long-term outcomes of bronchial thermoplasty in subjects with severe asthma: a comparison of 3-year follow-up results from two prospective multicentre studies." Geoffrey Chupp, Michel Laviolette, Lauren Cohn, Charlene McEvoy, Sandeep Bansal, Adrian S
    Eur Respir J. 2017;50.
    PubMed     Text format    


  58. HEEDERIK D
    Occupational exposure and asthma control.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  59. BOWATTE G, Erbas B, Lodge CJ, Knibbs LD, et al
    Traffic-related air pollution exposure over a 5-year period is associated with increased risk of asthma and poor lung function in middle age.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


    September 2017
  60. BUSH A, Pavord ID
    After the asthmas: Star Wars and Star Trek.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  61. ROBINSON DS, Kariyawasam HH, Heaney LG
    Phase three studies of biologics for severe asthma: could do better?
    Eur Respir J. 2017;50.
    PubMed     Text format    


  62. FRICKER M, Gibson PG
    Macrophage dysfunction in the pathogenesis and treatment of asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  63. TO T, Zhu J, Carlsten C, Larsen K, et al
    Do community demographics, environmental characteristics and access to care affect risks of developing ACOS and mortality in people with asthma?
    Eur Respir J. 2017;50.
    PubMed     Text format    


  64. O'BYRNE PM, Jenkins C, Bateman ED
    The paradoxes of asthma management: time for a new approach?
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  65. POLVERINO E, Goeminne PC, McDonnell MJ, Aliberti S, et al
    European Respiratory Society guidelines for the management of adult bronchiectasis.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  66. WENZEL SE, Brillhart S, Nowack K
    An invisible disease: severe asthma is more than just "bad asthma".
    Eur Respir J. 2017;50.
    PubMed     Text format    


  67. FOSTER JM, McDonald VM, Guo M, Reddel HK, et al
    "I have lost in every facet of my life": the hidden burden of severe asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available



  68. ERJ September Podcast: The hidden burden of severe asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  69. HEKKING PP, Loza MJ, Pavlidis S, De Meulder B, et al
    Transcriptomic gene signatures associated with persistent airflow limitation in patients with severe asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


    August 2017
  70. SIN DD, Leung JM, Wechsler ME
    Concern of underdiagnosing asthma-COPD overlap syndrome if age limit of 40 years for asthma is used.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  71. TOMMOLA M, Ilmarinen P, Tuomisto LE, Kankaanranta H, et al
    Concern of underdiagnosing asthma-COPD overlap syndrome if age limit of 40 years for asthma is used.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  72. BATEMAN ED, Guerreros AG, Brockhaus F, Holzhauer B, et al
    Fevipiprant, an oral prostaglandin DP2 receptor (CRTh2) antagonist, in allergic asthma uncontrolled on low-dose inhaled corticosteroids.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  73. PRETOLANI M, Soussan D, Poirier I, Thabut G, et al
    Clinical and biological characteristics of the French COBRA cohort of adult subjects with asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available



  74. ERJ August Podcast: Fevipiprant in allergic asthma not controlled by low-dose inhaled corticosteroids.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  75. MICHILS A, Haccuria A, Michiels S, Van Muylem A, et al
    Airway calibre variation is a major determinant of exhaled nitric oxide's ability to capture asthma control.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  76. THOMSON NC, Chanez P
    How effective is bronchial thermoplasty for severe asthma in clinical practice?
    Eur Respir J. 2017;50.
    PubMed     Text format    


  77. CHUPP G, Laviolette M, Cohn L, McEvoy C, et al
    Long-term outcomes of bronchial thermoplasty in subjects with severe asthma: a comparison of 3-year follow-up results from two prospective multicentre studies.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


    July 2017
  78. COTTIN V
    Combined pulmonary fibrosis and emphysema: bad and ugly all the same?
    Eur Respir J. 2017;50.
    PubMed     Text format    


  79. JACOB J, Bartholmai BJ, Rajagopalan S, Kokosi M, et al
    Functional and prognostic effects when emphysema complicates idiopathic pulmonary fibrosis.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


    June 2017
  80. CARPAIJ OA, Nieuwenhuis MAE, Koppelman GH, van den Berge M, et al
    Childhood factors associated with complete and clinical asthma remission at 25 and 49 years.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  81. MARTINEZ-GARCIA MA, Maiz-Carro L
    The challenge of defining exacerbation in bronchiectasis.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  82. HILL AT, Haworth CS, Aliberti S, Barker A, et al
    Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available



  83. "The burden of severe asthma in childhood and adolescence: results from the paediatric U-BIOPRED cohorts." Louise Fleming, Clare Murray, Aruna T. Bansal, Simone Hashimoto, Hans Bisgaard, Andrew Bush, Urs Frey, Gunilla Hedlin, Florian Singer, Wim M. va
    Eur Respir J. 2017;49.
    PubMed     Text format    



  84. "Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort." Dominick E. Shaw, Ana R. Sousa, Stephen J. Fowler, Louise J. Fleming, Graham Roberts, Julie Corfield, Ioannis Pandis, Aruna T. Bansal, Elisabeth H. Bel,
    Eur Respir J. 2017;49.
    PubMed     Text format    


  85. AL SALLAKH MA, Vasileiou E, Rodgers SE, Lyons RA, et al
    Defining asthma and assessing asthma outcomes using electronic health record data: a systematic scoping review.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  86. DUNICAN EM, Fahy JV
    Asthma and corticosteroids: time for a more precise approach to treatment.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  87. BERTHON BS, Gibson PG, Wood LG, MacDonald-Wicks LK, et al
    A sputum gene expression signature predicts oral corticosteroid response in asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    May 2017
  88. BUHL R, Humbert M, Bjermer L, Chanez P, et al
    Severe eosinophilic asthma: a roadmap to consensus.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  89. MIRAVITLLES M
    Diagnosis of asthma-COPD overlap: the five commandments.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  90. BOUSQUET J, Chavannes NH, Guldemond N, Haahtela T, et al
    Realising the potential of mHealth to improve asthma and allergy care: how to shape the future.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  91. MCDONALD VM, Gibson PG
    "To define is to limit": perspectives on asthma-COPD overlap syndrome and personalised medicine.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  92. HIMES BE, Ortega VE
    Making progress toward understanding the genetic architecture of asthma in the most affected US ethnic group.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  93. HERBERT C, Kumar RK
    Ambient air pollution and asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  94. MIRAVITLLES M, Alvarez-Gutierrez FJ, Calle M, Casanova C, et al
    Algorithm for identification of asthma-COPD overlap: consensus between the Spanish COPD and asthma guidelines.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  95. EDWARDS MR, Saglani S, Schwarze J, Skevaki C, et al
    Addressing unmet needs in understanding asthma mechanisms: From the European Asthma Research and Innovation Partnership (EARIP) Work Package (WP)2 collaborators.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  96. COSIO BG, Perez de Llano L, Lopez Vina A, Torrego A, et al
    Th-2 signature in chronic airway diseases: towards the extinction of asthma-COPD overlap syndrome?
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  97. TOMMOLA M, Ilmarinen P, Tuomisto LE, Lehtimaki L, et al
    Differences between asthma-COPD overlap syndrome and adult-onset asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  98. MASEFIELD S, Edwards J, Hansen K, Hamerlijnck D, et al
    The future of asthma research and development: a roadmap from the European Asthma Research and Innovation Partnership (EARIP).
    Eur Respir J. 2017;49.
    PubMed     Text format    


  99. PAPADOPOULOS NG, Androutsopoulou A, Akdis C, Dahlen SE, et al
    Asthma research in Europe: a transformative agenda for innovation and competitiveness.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  100. KOURI A, Boulet LP, Kaplan A, Gupta S, et al
    An evidence-based, point-of-care tool to guide completion of asthma action plans in practice.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  101. THOMSON NC
    Asthma and smoking-induced airway disease without spirometric COPD.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  102. AZAD MB, Vehling L, Lu Z, Dai D, et al
    Breastfeeding, maternal asthma and wheezing in the first year of life: a longitudinal birth cohort study.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  103. BONTEN TN, Kasteleyn MJ, de Mutsert R, Hiemstra PS, et al
    Defining asthma-COPD overlap syndrome: a population-based study.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  104. SIMPSON AJ, Honkoop PJ, Kennington E, Snoeck-Stroband JB, et al
    Perspectives of patients and healthcare professionals on mHealth for asthma self-management.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  105. BERAIR R, Hartley R, Mistry V, Sheshadri A, et al
    Associations in asthma between quantitative computed tomography and bronchial biopsy-derived airway remodelling.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  106. YAN Q, Brehm J, Pino-Yanes M, Forno E, et al
    A meta-analysis of genome-wide association studies of asthma in Puerto Ricans.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  107. HTET TD, Teede HJ, de Courten B, Loxton D, et al
    Asthma in reproductive-aged women with polycystic ovary syndrome and association with obesity.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  108. OLVEIRA C, Martinez-Garcia MA
    Health-related quality of life questionnaires in bronchiectasis: the simplest way to quantify complexity.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  109. SPINOU A, Siegert RJ, Guan WJ, Patel AS, et al
    The development and validation of the Bronchiectasis Health Questionnaire.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  110. AAMLI GAGNAT A, Gjerdevik M, Gallefoss F, Coxson HO, et al
    Incidence of non-pulmonary cancer and lung cancer by amount of emphysema and airway wall thickness: a community-based cohort.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  111. COATES AL, Wanger J, Cockcroft DW, Culver BH, et al
    ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    April 2017
  112. VALLIERES E, Tumelty K, Tunney MM, Hannah R, et al
    Efficacy of Pseudomonas aeruginosa eradication regimens in bronchiectasis.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  113. HILLIAM Y, Moore MP, Lamont IL, Bilton D, et al
    Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lung.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  114. FRIJA-MASSON J, Martin C, Regard L, Lothe MN, et al
    Bacteria-driven peribronchial lymphoid neogenesis in bronchiectasis and cystic fibrosis.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  115. O'DONNELL DE, Casaburi R, Frith P, Kirsten A, et al
    Effects of combined tiotropium/olodaterol on inspiratory capacity and exercise endurance in COPD.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  116. FANER R, Sibila O, Agusti A, Bernasconi E, et al
    The microbiome in respiratory medicine: current challenges and future perspectives.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  117. KNEIDINGER N, Milger K, Janitza S, Ceelen F, et al
    Lung volumes predict survival in patients with chronic lung allograft dysfunction.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    March 2017
  118. GRAS D, Martinez-Anton A, Bourdin A, Garulli C, et al
    Human bronchial epithelium orchestrates dendritic cell activation in severe asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  119. MUNOZ-CANO R, Torrego A, Bartra J, Sanchez-Lopez J, et al
    Follow-up of patients with uncontrolled asthma: clinical features of asthma patients according to the level of control achieved (the COAS study).
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  120. DEBRAY MP, Dombret MC, Pretolani M, Thabut G, et al
    Early computed tomography modifications following bronchial thermoplasty in patients with severe asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  121. BERGAUER A, Sopel N, Kross B, Vuorinen T, et al
    Rhinovirus species/genotypes and interferon-lambda: subtypes, receptor and polymorphisms - missing pieces of the puzzle of childhood asthma?
    Eur Respir J. 2017;49.
    PubMed     Text format    


  122. SCAGNOLARI C, Midulla F, Nenna R, Papoff P, et al
    Rhinovirus species/genotypes and interferon-lambda: subtypes, receptor and polymorphisms - missing pieces of the puzzle of childhood asthma?
    Eur Respir J. 2017;49.
    PubMed     Text format    


  123. BERGAUER A, Sopel N, Kross B, Vuorinen T, et al
    IFN-alpha/IFN-lambda responses to respiratory viruses in paediatric asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  124. STERK PJ
    A good asthma catch by professional fishing.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  125. BARALDO S, Papi A, Saetta M, Contoli M, et al
    IFN-alpha/IFN-lambda responses to respiratory viruses in paediatric asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  126. REINKE SN, Gallart-Ayala H, Gomez C, Checa A, et al
    Metabolomics analysis identifies different metabotypes of asthma severity.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  127. STOCKLEY JA, Ismail AM, Hughes SM, Edgar R, et al
    Maximal mid-expiratory flow detects early lung disease in alpha1-antitrypsin deficiency.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  128. LEDUC C, Antoni D, Charloux A, Falcoz PE, et al
    Comorbidities in the management of patients with lung cancer.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  129. PERSSON LJ, Aanerud M, Hardie JA, Miodini Nilsen R, et al
    Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  130. HUSEBO GR, Gronseth R, Lerner L, Gyuris J, et al
    Growth differentiation factor-15 is a predictor of important disease outcomes in patients with COPD.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  131. WEDZICHA JA ERS CO-CHAIR, Miravitlles M, Hurst JR, Calverley PM, et al
    Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  132. NEDER JA, Berton DC, Arbex FF, Alencar MC, et al
    Physiological and clinical relevance of exercise ventilatory efficiency in COPD.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  133. CROOK S, Busching G, Schultz K, Lehbert N, et al
    A multicentre validation of the 1-min sit-to-stand test in patients with COPD.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  134. WILLIAMS MT, John D, Frith P
    Comparison of the Dyspnoea-12 and Multidimensional Dyspnoea Profile in people with COPD.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  135. VOGELMEIER CF, Criner GJ, Martinez FJ, Anzueto A, et al
    Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    February 2017
  136. PAPI A, Saetta M, Fabbri L
    Severe asthma: phenotyping to endotyping or vice versa?
    Eur Respir J. 2017;49.
    PubMed     Text format    


  137. KUO CS, Pavlidis S, Loza M, Baribaud F, et al
    T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPRED.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  138. BRUMPTON B, Mai XM, Langhammer A, Laugsand LE, et al
    Prospective study of insomnia and incident asthma in adults: the HUNT study.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  139. ZOLLER B, Pirouzifard M, Memon AA, Sundquist J, et al
    Risk of pulmonary embolism and deep venous thrombosis in patients with asthma: a nationwide case-control study from Sweden.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  140. LORX A, Czovek D, Gingl Z, Makan G, et al
    Airway dynamics in COPD patients by within-breath impedance tracking: effects of continuous positive airway pressure.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  141. MOLIMARD M, Raherison C, Lignot S, Balestra A, et al
    Chronic obstructive pulmonary disease exacerbation and inhaler device handling: real-life assessment of 2935 patients.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  142. LOWES D, Al-Shair K, Newton PJ, Morris J, et al
    Predictors of mortality in chronic pulmonary aspergillosis.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    January 2017
  143. BAHMER T, Waschki B, Schatz F, Herzmann C, et al
    Physical activity, airway resistance and small airway dysfunction in severe asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  144. DE-TORRES JP, Sanchez-Salcedo P, Bastarrika G, Alcaide AB, et al
    Telomere length, COPD and emphysema as risk factors for lung cancer.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  145. GRIGG J
    Tiotropium in paediatric asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  146. ELLWOOD P, Asher MI, Billo NE, Bissell K, et al
    The Global Asthma Network rationale and methods for Phase I global surveillance: prevalence, severity, management and risk factors.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available



  147. ERJ January Podcast: the BioSHaRE approach to understanding of the effects of air pollution on asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  148. ALIBERTI S, Dhar R, Aksamit TR, Morgan L, et al
    Additional important research priorities for bronchiectasis in China.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  149. GUAN WJ, Gao YH, Yuan JJ, Chen RC, et al
    Additional important research priorities for bronchiectasis in China.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  150. KARIMI R, Tornling G, Forsslund H, Mikko M, et al
    Differences in regional air trapping in current smokers with normal spirometry.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  151. BENMERAD M, Slama R, Botturi K, Claustre J, et al
    Chronic effects of air pollution on lung function after lung transplantation in the Systems prediction of Chronic Lung Allograft Dysfunction (SysCLAD) study.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  152. KUNZ LI, Ten Hacken NH, Lapperre TS, Timens W, et al
    Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  153. GREULICH T, Nell C, Hohmann D, Grebe M, et al
    The prevalence of diagnosed alpha1-antitrypsin deficiency and its comorbidities: results from a large population-based database.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    December 2016
  154. GAGA M, Zervas E, Humbert M
    Targeting immunoglobulin E in non-atopic asthma: crossing the red line?
    Eur Respir J. 2016;48:1538-1540.
    PubMed     Text format    


    November 2016
  155. BERGAUER A, Sopel N, Kross B, Vuorinen T, et al
    IFN-alpha/IFN-lambda responses to respiratory viruses in paediatric asthma.
    Eur Respir J. 2016 Nov 11. pii: ERJ-00969-2016. doi: 10.1183/13993003.00969-2016
    PubMed     Text format     Abstract available


  156. SHIN S, Park HY, Kim H, Kim HK, et al
    Joint effect of airflow limitation and emphysema on postoperative outcomes in early-stage nonsmall cell lung cancer.
    Eur Respir J. 2016 Nov 3. pii: ERJ-01148-2016. doi: 10.1183/13993003.01148-2016.
    PubMed     Text format     Abstract available


  157. HAMELMANN E, Bernstein JA, Vandewalker M, Moroni-Zentgraf P, et al
    A randomised controlled trial of tiotropium in adolescents with severe symptomatic asthma.
    Eur Respir J. 2016 Nov 3. pii: ERJ-01100-2016. doi: 10.1183/13993003.01100-2016.
    PubMed     Text format     Abstract available


  158. LEZMI G, Galmiche-Rolland L, Rioux S, Jaubert F, et al
    Mast cells are associated with exacerbations and eosinophilia in children with severe asthma.
    Eur Respir J. 2016;48:1320-1328.
    PubMed     Text format     Abstract available


  159. WILSON SJ, Ward JA, Sousa AR, Corfield J, et al
    Severe asthma exists despite suppressed tissue inflammation: findings of the U-BIOPRED study.
    Eur Respir J. 2016;48:1307-1319.
    PubMed     Text format     Abstract available


  160. FLEMING L, Saglani S, Bush A
    Asthma attacks: should we nail our colours to the mast (cell)?
    Eur Respir J. 2016;48:1261-1264.
    PubMed     Text format    


  161. HASEGAWA K, Mansbach JM, Ajami NJ, Espinola JA, et al
    Association of nasopharyngeal microbiota profiles with bronchiolitis severity in infants hospitalised for bronchiolitis.
    Eur Respir J. 2016;48:1329-1339.
    PubMed     Text format     Abstract available


    October 2016
  162. CAI Y, Zijlema WL, Doiron D, Blangiardo M, et al
    Ambient air pollution, traffic noise and adult asthma prevalence: a BioSHaRE approach.
    Eur Respir J. 2016 Oct 20. pii: ERJ-02127-2015. doi: 10.1183/13993003.02127-2015
    PubMed     Text format     Abstract available


  163. PILLAI P, Chan YC, Wu SY, Ohm-Laursen L, et al
    Omalizumab reduces bronchial mucosal IgE and improves lung function in non-atopic asthma.
    Eur Respir J. 2016 Oct 20. pii: ERJ-01501-2015. doi: 10.1183/13993003.01501-2015
    PubMed     Text format     Abstract available


  164. CHEN YC, Liou TH, Chen PC, Chiang BL, et al
    Growth trajectories and asthma/rhinitis in children: a longitudinal study in Taiwan.
    Eur Respir J. 2016 Oct 20. pii: ERJ-00741-2016. doi: 10.1183/13993003.00741-2016
    PubMed     Text format     Abstract available


  165. CHEN W, Lynd LD, FitzGerald JM, Marra CA, et al
    Excess medical costs in patients with asthma and the role of comorbidity.
    Eur Respir J. 2016 Oct 6. pii: ERJ-01141-2016. doi: 10.1183/13993003.01141-2016.
    PubMed     Text format     Abstract available


  166. SCHWARZE J, Fitch PM, Heimweg J, Errington C, et al
    Viral mimic poly-(I:C) attenuates airway epithelial T-cell suppressive capacity: implications for asthma.
    Eur Respir J. 2016 Oct 6. pii: ERJ-00841-2016. doi: 10.1183/13993003.00841-2016.
    PubMed     Text format    


  167. MAGNUS MC, Haberg SE, Magnus P, Engeland A, et al
    Pre-eclampsia and childhood asthma.
    Eur Respir J. 2016 Oct 6. pii: ERJ-00673-2016. doi: 10.1183/13993003.00673-2016.
    PubMed     Text format     Abstract available


  168. MAO B, Yang JW, Lu HW, Xu JF, et al
    Asthma and risk of bronchiectasis exacerbation: we still need more evidence.
    Eur Respir J. 2016;48:1247-1248.
    PubMed     Text format    


  169. GAO YH, Guan WJ, Chen RC, Zhang GJ, et al
    Asthma and risk of bronchiectasis exacerbation: we still need more evidence.
    Eur Respir J. 2016;48:1246-1247.
    PubMed     Text format    


  170. POYNTER ME, Irvin CG
    Interleukin-6 as a biomarker for asthma: hype or is there something else?
    Eur Respir J. 2016;48:979-981.
    PubMed     Text format    


  171. HAMBLETON K, Pavord ID
    What can we learn from blood granulocyte patterns in patients with asthma?
    Eur Respir J. 2016;48:976-978.
    PubMed     Text format    


    September 2016
  172. TOMMOLA M, Ilmarinen P, Tuomisto LE, Haanpaa J, et al
    The effect of smoking on lung function: a clinical study of adult-onset asthma.
    Eur Respir J. 2016 Sep 22. pii: ERJ-00850-2016. doi: 10.1183/13993003.00850-2016
    PubMed     Text format     Abstract available



  173. ERJ September Podcast: research priorities in bronchiectasis.
    Eur Respir J. 2016;48:E69.
    PubMed     Text format    


  174. VAN DEN WIJNGAART LS, Roukema J, Merkus PJ
    Monitoring asthma: no matter how?
    Eur Respir J. 2016;48:614-6.
    PubMed     Text format    


  175. ROBINSON DS
    Assessing severe asthma.
    Eur Respir J. 2016;48:611-3.
    PubMed     Text format    


  176. GRAS D, Chanez P
    New sociology for better understanding severe eosinophilic asthma: introducing the SOCS family.
    Eur Respir J. 2016;48:608-10.
    PubMed     Text format    


  177. AHMADIZAR F, Vijverberg SJ, Arets HG, de Boer A, et al
    Childhood obesity in relation to poor asthma control and exacerbation: a meta-analysis.
    Eur Respir J. 2016 Sep 1. pii: ERJ-00766-2016. doi: 10.1183/13993003.00766-2016.
    PubMed     Text format     Abstract available


    August 2016
  178. ILMARINEN P, Tuomisto LE, Niemela O, Danielsson J, et al
    Comorbidities and elevated IL-6 associate with negative outcome in adult-onset asthma.
    Eur Respir J. 2016 Aug 18. pii: ERJ-02198-2015. doi: 10.1183/13993003.02198-2015
    PubMed     Text format     Abstract available


  179. NADIF R, Siroux V, Boudier A, le Moual N, et al
    Blood granulocyte patterns as predictors of asthma phenotypes in adults from the EGEA study.
    Eur Respir J. 2016 Aug 4. pii: ERJ-00336-2016. doi: 10.1183/13993003.00336-2016.
    PubMed     Text format     Abstract available


  180. LEHTIMAKI L, Csonka P, Makinen E, Isojarvi J, et al
    Predictive value of exhaled nitric oxide in the management of asthma: a systematic review.
    Eur Respir J. 2016 Aug 4. pii: ERJ-00699-2016. doi: 10.1183/13993003.00699-2016.
    PubMed     Text format     Abstract available


  181. KING GG, Thamrin C
    Complex lung function in severe asthma: seeing is believing.
    Eur Respir J. 2016;48:294-6.
    PubMed     Text format    


  182. PETERS MC, Fahy JV
    Metabolic consequences of obesity as an "outside in" mechanism of disease severity in asthma.
    Eur Respir J. 2016;48:291-3.
    PubMed     Text format    


  183. BARALDO S, Turato G, Cosio MG, Saetta M, et al
    Which CD8+ T-cells in asthma? Attacking or defending?
    Eur Respir J. 2016;48:287-90.
    PubMed     Text format    


    July 2016
  184. USEMANN J, Fuchs O, Anagnostopoulou P, Korten I, et al
    Predictive value of exhaled nitric oxide in healthy infants for asthma at school age.
    Eur Respir J. 2016 Jul 7. pii: ERJ-00439-2016. doi: 10.1183/13993003.00439-2016.
    PubMed     Text format    



  185. "Tidal flow variability measured by impedance pneumography relates to childhood asthma risk." Ville-Pekka Seppa, Anna S. Pelkonen, Anne Kotaniemi-Syrjanen, Jari Viik, Mika J. Makela and L. Pekka Malmberg. Eur Respir J 2016; 47: 1687-1696.
    Eur Respir J. 2016;48:285.
    PubMed     Text format    


    June 2016
  186. VAN DER MEER AN, Pasma H, Kempenaar-Okkema W, Pelinck JA, et al
    A 1-day visit in a severe asthma centre: effect on asthma control, quality of life and healthcare use.
    Eur Respir J. 2016 Jun 23. pii: ERJ-00220-2016. doi: 10.1183/13993003.00220-2016
    PubMed     Text format     Abstract available


  187. SIN DD, Miravitlles M, Mannino DM, Soriano JB, et al
    What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion.
    Eur Respir J. 2016 Jun 23. pii: ERJ-00436-2016. doi: 10.1183/13993003.00436-2016
    PubMed     Text format     Abstract available


  188. DORAN E, Choy DF, Shikotra A, Butler CA, et al
    Reduced epithelial suppressor of cytokine signalling 1 in severe eosinophilic asthma.
    Eur Respir J. 2016 Jun 23. pii: ERJ-00400-2015. doi: 10.1183/13993003.00400-2015
    PubMed     Text format     Abstract available


  189. FISHER JA, Puett RC, Hart JE, Camargo CA Jr, et al
    Particulate matter exposures and adult-onset asthma and COPD in the Nurses' Health Study.
    Eur Respir J. 2016 Jun 10. pii: ERJ-00845-2015. doi: 10.1183/13993003.00845-2015
    PubMed     Text format    


  190. ALIBERTI S, Masefield S, Polverino E, De Soyza A, et al
    Research priorities in bronchiectasis: a consensus statement from the EMBARC Clinical Research Collaboration.
    Eur Respir J. 2016 Jun 10. pii: ERJ-01888-2015. doi: 10.1183/13993003.01888-2015
    PubMed     Text format     Abstract available



  191. "Asthma inhaler adherence determinants in adults: systematic review of observational data." Alexandra L. Dima, Gimena Hernandez, Oriol Cunillera, Montserrat Ferrer, Marijn de Bruin and the ASTRO-LAB group. Eur Respir J 2015; 45: 994-1018.
    Eur Respir J. 2016;47:1892.
    PubMed     Text format    


  192. SORIANO JB, Serrano J
    Bronchiectasthma and asthmectasis!
    Eur Respir J. 2016;47:1597-600.
    PubMed     Text format    


    May 2016
  193. DEN OTTER I, Willems LN, van Schadewijk A, van Wijngaarden S, et al
    Lung function decline in asthma patients with elevated bronchial CD8, CD4 and CD3 cells.
    Eur Respir J. 2016 May 26. pii: ERJ-01525-2015. doi: 10.1183/13993003.01525-2015
    PubMed     Text format     Abstract available


  194. SUBRAMANIAN DR, Gupta S, Burggraf D, Vom Silberberg SJ, et al
    Emphysema- and airway-dominant COPD phenotypes defined by standardised quantitative computed tomography.
    Eur Respir J. 2016 May 26. pii: ERJ-01878-2015. doi: 10.1183/13993003.01878-2015
    PubMed     Text format     Abstract available


  195. DUCHARME FM, Gagnon R, Benard B, Tse SM, et al
    Cessation of long-acting beta2-agonist in children with persistent asthma on inhaled corticosteroids.
    Eur Respir J. 2016 May 26. pii: ERJ-00014-2016. doi: 10.1183/13993003.00014-2016
    PubMed     Text format    


  196. VASBINDER EC, Goossens LM, Rutten-van Molken MP, de Winter BC, et al
    e-Monitoring of Asthma Therapy to Improve Compliance in children (e-MATIC): a randomised controlled trial.
    Eur Respir J. 2016 May 26. pii: ERJ-01698-2015. doi: 10.1183/13993003.01698-2015
    PubMed     Text format     Abstract available


  197. CHIH AH, Chen YC, Tu YK, Huang KC, et al
    Mediating pathways from central obesity to childhood asthma: a population-based longitudinal study.
    Eur Respir J. 2016 May 12. pii: ERJ-00226-2016. doi: 10.1183/13993003.00226-2016
    PubMed     Text format     Abstract available


  198. SVENNINGSEN S, Nair P, Guo F, McCormack DG, et al
    Is ventilation heterogeneity related to asthma control?
    Eur Respir J. 2016 May 12. pii: ERJ-00393-2016. doi: 10.1183/13993003.00393-2016
    PubMed     Text format     Abstract available


    April 2016
  199. HOFFMANN J, Wilhelm J, Olschewski A, Kwapiszewska G, et al
    Microarray analysis in pulmonary hypertension.
    Eur Respir J. 2016 Apr 13. pii: ERJ-02030-2015. doi: 10.1183/13993003.02030-2015
    PubMed     Text format     Abstract available


  200. LUM S, Stocks J
    Inclusion of children with airway disease for the development of spirometry reference data.
    Eur Respir J. 2016;47:1292-3.
    PubMed     Text format    


  201. HULS A, Kramer U, Schuster A, Gappa M, et al
    Inclusion of children with airway disease for the development of spirometry reference data.
    Eur Respir J. 2016;47:1290-2.
    PubMed     Text format    


  202. GOMEZ C, Chanez P
    The lung microbiome: the perfect culprit for COPD exacerbations?
    Eur Respir J. 2016;47:1034-6.
    PubMed     Text format    


  203. BOUSQUET J, Barbara C, Bateman E, Bel E, et al
    AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation.
    Eur Respir J. 2016;47:1028-33.
    PubMed     Text format    


  204. SPRUIT MA, Franssen FM, Rutten EP, Wopereis S, et al
    A new perspective on COPD exacerbations: monitoring impact by measuring physical, psychological and social resilience.
    Eur Respir J. 2016;47:1024-7.
    PubMed     Text format    


  205. COSTA C, Traves SL, Tudhope SJ, Fenwick PS, et al
    Enhanced monocyte migration to CXCR3 and CCR5 chemokines in COPD.
    Eur Respir J. 2016;47:1093-102.
    PubMed     Text format     Abstract available


  206. CHARUSUSIN N, Gosselink R, McConnell A, Demeyer H, et al
    Inspiratory muscle training improves breathing pattern during exercise in COPD patients.
    Eur Respir J. 2016;47:1261-4.
    PubMed     Text format    


  207. WANG Z, Bafadhel M, Haldar K, Spivak A, et al
    Lung microbiome dynamics in COPD exacerbations.
    Eur Respir J. 2016;47:1082-92.
    PubMed     Text format     Abstract available


  208. DIZIER MH, Nadif R, Margaritte-Jeannin P, Barton SJ, et al
    Interaction between the DNAH9 gene and early smoke exposure in bronchial hyperresponsiveness.
    Eur Respir J. 2016;47:1072-81.
    PubMed     Text format     Abstract available


  209. MUMBY S, Saito J, Adcock IM, Chung KF, et al
    Decreased breath excretion of redox active iron in COPD: a protective failure?
    Eur Respir J. 2016;47:1267-70.
    PubMed     Text format    


    March 2016
  210. MILARA J, Escriva J, Ortiz JL, Juan G, et al
    Vascular effects of sildenafil in patients with pulmonary fibrosis and pulmonary hypertension: an ex vivo/in vitro study.
    Eur Respir J. 2016 Mar 23. pii: ERJ-01259-2015. doi: 10.1183/13993003.01259-2015
    PubMed     Text format     Abstract available


  211. KOLAHIAN S, Oz HH, Zhou B, Griessinger CM, et al
    The emerging role of myeloid-derived suppressor cells in lung diseases.
    Eur Respir J. 2016;47:967-77.
    PubMed     Text format     Abstract available


  212. BARTOLI ML, Costa F, Malagrino L, Nieri D, et al
    Sputum inflammatory cells in COPD patients classified according to GOLD 2011 guidelines.
    Eur Respir J. 2016;47:978-80.
    PubMed     Text format    


  213. ZAIGHAM S, Wollmer P, Engstrom G
    Lung function, forced expiratory volume in 1 s decline and COPD hospitalisations over 44 years of follow-up.
    Eur Respir J. 2016;47:742-50.
    PubMed     Text format     Abstract available


    February 2016
  214. BOLAND AC, Hodgekiss C, Hicks F, Edwards A, et al
    Improving end-of-life communication between primary and secondary care within respiratory medicine.
    Eur Respir J. 2016;47:658-60.
    PubMed     Text format    


  215. MOSS RB
    Treating allergic bronchopulmonary aspergillosis: the way forward.
    Eur Respir J. 2016;47:385-7.
    PubMed     Text format    


  216. SORIANO JB, Suissa S
    Ageing lungs and very elderly COPD: anytime and anywhere.
    Eur Respir J. 2016;47:379-81.
    PubMed     Text format    


  217. LANKEIT M, Held M
    Incidence of venous thromboembolism in COPD: linking inflammation and thrombosis?
    Eur Respir J. 2016;47:369-73.
    PubMed     Text format    


  218. AGUSTI A, Bel E, Thomas M, Vogelmeier C, et al
    Treatable traits: toward precision medicine of chronic airway diseases.
    Eur Respir J. 2016;47:410-9.
    PubMed     Text format     Abstract available


  219. PUENTE-MAESTU L, Palange P, Casaburi R, Laveneziana P, et al
    Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement.
    Eur Respir J. 2016;47:429-60.
    PubMed     Text format     Abstract available


  220. MIRAVITLLES M, Vogelmeier C, Roche N, Halpin D, et al
    A review of national guidelines for management of COPD in Europe.
    Eur Respir J. 2016;47:625-37.
    PubMed     Text format     Abstract available


  221. RODRIGUEZ-ROISIN R, Bartolome SD, Huchon G, Krowka MJ, et al
    Inflammatory bowel diseases, chronic liver diseases and the lung.
    Eur Respir J. 2016;47:638-50.
    PubMed     Text format     Abstract available


  222. LUOTO JA, Elmstahl S, Wollmer P, Pihlsgard M, et al
    Incidence of airflow limitation in subjects 65-100 years of age.
    Eur Respir J. 2016;47:461-72.
    PubMed     Text format     Abstract available


  223. BORVIK T, Braekkan SK, Enga K, Schirmer H, et al
    COPD and risk of venous thromboembolism and mortality in a general population.
    Eur Respir J. 2016;47:473-81.
    PubMed     Text format     Abstract available


  224. MAGNUSSEN H, Tetzlaff K, Bateman ED, Watz H, et al
    Lung function changes over time following withdrawal of inhaled corticosteroids in patients with severe COPD.
    Eur Respir J. 2016;47:651-4.
    PubMed     Text format    


  225. GARDEN FL, Simpson JM, Mellis CM, Marks GB, et al
    Change in the manifestations of asthma and asthma-related traits in childhood: a latent transition analysis.
    Eur Respir J. 2016;47:499-509.
    PubMed     Text format     Abstract available


    January 2016
  226. ELLIOTT L, von Essen S
    COPD in farmers: what have we learnt?
    Eur Respir J. 2016;47:16-8.
    PubMed     Text format    


  227. SANSORES RH, Ramirez-Venegas A
    COPD in women: susceptibility or vulnerability?
    Eur Respir J. 2016;47:19-22.
    PubMed     Text format    


  228. WELTE T
    Acute exacerbation in COPD: we must do more.
    Eur Respir J. 2016;47:14-5.
    PubMed     Text format    


  229. LAHOUSSE L, Moyse E, Krantic S, Brusselle GG, et al
    Understanding age-related diseases: report of the 2015 Ageing Summit.
    Eur Respir J. 2016;47:5-9.
    PubMed     Text format    


  230. SHAHEEN SO, Macdonald-Wallis C, Lawlor DA, Henderson AJ, et al
    Hypertensive disorders of pregnancy, respiratory outcomes and atopy in childhood.
    Eur Respir J. 2016;47:156-65.
    PubMed     Text format     Abstract available


  231. HARTL S, Lopez-Campos JL, Pozo-Rodriguez F, Castro-Acosta A, et al
    Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD Audit.
    Eur Respir J. 2016;47:113-21.
    PubMed     Text format     Abstract available


  232. GUILLIEN A, Puyraveau M, Soumagne T, Guillot S, et al
    Prevalence and risk factors for COPD in farmers: a cross-sectional controlled study.
    Eur Respir J. 2016;47:95-103.
    PubMed     Text format     Abstract available


  233. CURROW DC, Abernethy AP, Allcroft P, Banzett RB, et al
    The need to research refractory breathlessness.
    Eur Respir J. 2016;47:342-3.
    PubMed     Text format    


  234. LEAHY TR, McManus R, Doherty DG, Grealy R, et al
    Interleukin-15 is associated with disease severity in viral bronchiolitis.
    Eur Respir J. 2016;47:212-22.
    PubMed     Text format     Abstract available


  235. LAZAR Z, Mullner N, Lucattelli M, Ayata CK, et al
    NTPDase1/CD39 and aberrant purinergic signalling in the pathogenesis of COPD.
    Eur Respir J. 2016;47:254-63.
    PubMed     Text format     Abstract available


  236. MOTTE S, Melot C, Di Pierdomenico L, Martins D, et al
    Predictors of costs from the hospital perspective of primary pulmonary embolism.
    Eur Respir J. 2016;47:203-11.
    PubMed     Text format     Abstract available


  237. RADEMACHER J, Schulz A, Hedtfeld S, Stanke F, et al
    Nasal potential difference of carriers of the W493R ENaC variant with non-cystic fibrosis bronchiectasis.
    Eur Respir J. 2016;47:322-4.
    PubMed     Text format    


  238. GABROVSKA M, Lacombe E, Bruyneel M, Ninane V, et al
    Acute bronchospasm during passive exposure to bronchial provocation tests.
    Eur Respir J. 2016;47:320-2.
    PubMed     Text format    


  239. YANG JY, Oh SY, Song JW, Shim TS, et al
    Restrictive chronic lung function decline after haematopoietic stem cell transplantation.
    Eur Respir J. 2016;47:336-9.
    PubMed     Text format    


  240. SUISSA S
    Number needed to treat: enigmatic results for exacerbations in COPD.
    Eur Respir J. 2016;47:354-5.
    PubMed     Text format    


  241. LETTIS S, Keene O
    Number needed to treat: enigmatic results for exacerbations in COPD.
    Eur Respir J. 2016;47:353-4.
    PubMed     Text format    


    December 2015
  242. POPOVIC M, Rusconi F, Zugna D, Galassi C, et al
    Prenatal exposure to antibiotics and wheezing in infancy: a birth cohort study.
    Eur Respir J. 2015 Dec 2. pii: ERJ-00315-2015. doi: 10.1183/13993003.00315-2015.
    PubMed     Text format     Abstract available


    October 2015
  243. COX DW, Mullane D, Zhang GC, Turner SW, et al
    Longitudinal assessment of airway responsiveness from 1 month to 18 years in the PIAF birth cohort.
    Eur Respir J. 2015 Oct 22. pii: ERJ-00397-2015. doi: 10.1183/13993003.00397-2015
    PubMed     Text format     Abstract available


  244. YAMMINE S, Schmidt A, Sutter O, Fouzas S, et al
    Functional evidence for continued alveolarisation in former preterms at school age?
    Eur Respir J. 2015 Oct 22. pii: ERJ-00478-2015. doi: 10.1183/13993003.00478-2015
    PubMed     Text format     Abstract available


    August 2015
  245. MCKEON NJ, Timmins SN, Stewart H, Yerkovich ST, et al
    Diagnosis of COPD before cardiac surgery.
    Eur Respir J. 2015 Aug 20. pii: ERJ-02339-2014. doi: 10.1183/13993003.02339-2014
    PubMed     Text format    


    July 2015
  246. GAUVREAU GM, El-Gammal AI, O'Byrne PM
    Allergen-induced airway responses.
    Eur Respir J. 2015 Jul 23. pii: ERJ-00536-2015. doi: 10.1183/13993003.00536-2015
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: